Bottom line
How much do IHE and PRHSX overlap?
40% of their top holdings overlap by weight. 4 securities appear in both funds' top 25, making up 53.6% of IHE's assets and 27.0% of PRHSX's. They share a meaningful core but differ in the rest of the portfolio.
PRHSX holds far more positions (279 vs 59), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings IHE and PRHSX have in common
| Holding | % of IHE | % of PRHSX | Overlap |
|---|---|---|---|
| Johnson & Johnson | 22.44% | 6.63% | 6.63% |
| Eli Lilly And Company | 22.25% | 14.28% | 14.28% |
| Merck & Co., Inc. | 4.55% | 4.01% | 4.01% |
| Bristol-myers Squibb Company | 4.37% | 2.11% | 2.11% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in IHE
- BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 6.24%
- Royalty Pharma Plc — 4.34%
- Viatris Inc. — 4.22%
- Pfizer Inc. — 3.96%
- Zoetis Inc. — 3.73%
- Jazz Pharmaceuticals Public Limited Company — 3.45%
- Elanco Animal Health Incorporated — 2.81%
- Axsome Therapeutics, Inc. — 2.42%
- Corcept Therapeutics Incorporated — 1.90%
- Ligand Pharmaceuticals Incorporated — 1.45%
- Definium Therapeutics Inc — 1.39%
- Liquidia Corp — 1.28%
- Indivior Pharmaceuticals, Inc. — 1.14%
- Crinetics Pharmaceuticals Inc — 0.90%
- Organon & Co. — 0.81%
Only in PRHSX
- Unitedhealth Group Inc — 5.99%
- Abbvie Inc — 5.10%
- Gilead Sciences Inc — 2.82%
- Thermo Fisher Scientific Inc — 2.52%
- Vertex Pharmaceuticals Inc — 2.28%
- Abbott Laboratories — 1.89%
- Intuitive Surgical Inc — 1.87%
- Amgen Inc — 1.82%
- Stryker Corp — 1.78%
- Elevance Health Inc — 1.53%
- Natera Inc — 1.44%
- Danaher Corp — 1.43%
- Guardant Health Inc — 1.23%
- Cardinal Health Inc — 1.03%
- Royalty Pharma Plc- Cl A — 0.97%
Asset mix
| Asset type | IHE | PRHSX |
|---|---|---|
| Stocks | 99.9% | 96.4% |
| Cash & short-term funds | 6.3% | 0.7% |
| Preferred stock | — | 3.0% |
| Bonds | — | 0.2% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Country mix
| Country | IHE | PRHSX |
|---|---|---|
| US | 96.4% | 92.6% |
| GB | 4.3% | 1.7% |
| IE | 3.8% | 0.8% |
| CA | 1.4% | 0.6% |
| NL | — | 1.0% |
| BM | — | 0.7% |
| DK | — | 0.7% |
| CH | — | 0.5% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do IHE and PRHSX overlap?
What stocks do IHE and PRHSX have in common?
Should I own both IHE and PRHSX?
Which holds more stocks, IHE or PRHSX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.